GSK and Spero ended a Phase 3 trial early meeting efficacy goals in cUTIs, positioning its treatment as the first oral ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

Market Overview: The Global Nasal Polyposis Drugs Market is expanding rapidly, owing to advances in biologic medicines, minimally invasive surgical procedures, and personalized medicine approaches.

The smart inhalers market is experiencing significant growth, driven by the increasing incidence of respiratory diseases like asthma and COPD, technological advancements, widespread smartphone usage, ...

LONDON, GREATER LONDON, UNITED KINGDOM, May 29, 2025 /EINPresswire.com/ -- The urticaria market size has surged from $4.03 billion in 2024 to $4.77 billion in 2025, achieving a substantial compound ...

Credit: PeopleImages.com – Yuri A via Shutterstock. Just two weeks after dropping a TIGIT candidate jointly developed with GSK, iTeos has announced plans to wind down operations and explore strategic ...

Eli Lilly said yesterday that it will acquire SiteOne Therapeutics, a biotech developing non-opioid pain drugs, for up to $1 ...

GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Service Income and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 31-03-2025, ...

The DRW CEO discusses the intersection of traditional finance, blockchain technology and emerging markets, the innovations spurring change, and the challenges that digital markets face in becoming ...

Letters to the editor are welcome. Please send letters, which have not been published elsewhere, to [email protected]. Letters may be up to 350 words and can also include pictures. Indicate ...